This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Laurent Humeau
VP R&D at Inovio Pharma


As Chief Scientific Officer, Dr. Humeau works to ensure continuous and strategic growth of Inovio’s pipeline by introducing a constant flow of innovative concepts and cycling them from early stage discovery and development through clinical application and patient monitoring. He provides technical and strategic leadership across multiple teams that are essential to upstream and downstream verticals of clinical development.

Dr. Humeau leads with a collaborative spirit and deeply believes in the company’s core values. He is a valuable member of the leadership team who greatly contributes to Inovio’s culture. Prior to Inovio, Dr. Humeau was Senior Director of Translational Research, Human Therapeutics Division for Intrexon and previously Chief Scientific Officer, Vice President of R&D at VIRxSYS Corporation. Dr. Humeau holds a Ph.D., summa cum laude, from Denis Diderot/Paris 7 University and a MS degree from Pierre & Marie Curie/Paris 6 University, Paris, France.

Agenda Sessions

  • Synthetic DNA-encoded Monoclonal Antibody (dMAbTM) for in vivo Antibody Production: From Mouse to Human